Valuation : Haleon plc

Market Cap 32.43B 43.95B 37.84B 35.53B 60.93B 4,182B 61.37B 421B 164B 2,121B 165B 161B 7,021B P/E 2026 *
19.2x
P/E 2027 * 16.9x
Enterprise Value 39.31B 53.27B 45.86B 43.06B 73.85B 5,068B 74.37B 510B 199B 2,570B 200B 196B 8,510B EV / Sales 2026 *
3.45x
EV / Sales 2027 * 3.26x
Free-Float
98.46%
Yield 2026 *
2.19%
Yield 2027 * 2.43%

Last Transcript : Haleon plc

1 day-0.35%
1 week+1.40%
Current month+1.35%
1 month-0.11%
3 months+9.36%
6 months-7.93%
Current year-1.76%
1 week 364.7
Extreme 364.7
374.6
1 month 348.8
Extreme 348.8
374.6
Current year 317.8
Extreme 317.8
416.1
1 year 274.4
Extreme 274.4
416.1
3 years 274.4
Extreme 274.4
419.5
5 years 241.17
Extreme 241.1735
419.5
10 years 241.17
Extreme 241.1735
419.5
Manager TitleAgeSince
Chief Executive Officer 59 2021-07-21
Director of Finance/CFO 57 2024-10-31
Chief Tech/Sci/R&D Officer 63 2025-07-31
Director TitleAgeSince
Director/Board Member 59 2022-05-22
Chairman 71 2025-12-31
Director/Board Member 59 2022-07-17
Date Insider Type Main position Quantity % Market Cap. Importance
6/30/26 Free

Chief Financial Officer

283,193 0.0032%
6/30/26 Tax

Chief Financial Officer

-133,301 0.0015%
5/19/26 Others 4,415 0.0000% -
Change 5-day change 1-year change 3-year change Capi.($)
-0.35%+1.40%+1.46%+13.08% 43.98B
-1.37%-7.39%+57.08%+108.37% 1,047B
-0.86%-2.55%+49.44%+64.58% 646B
+0.81%-2.70%+21.45%+75.14% 451B
-1.64%-4.75%+35.59%+35.54% 355B
-0.39%-2.76%+21.39%+38.01% 291B
-1.19%-2.21%+1.53%+11.51% 252B
-0.47%-3.08%+49.92%+67.80% 234B
-1.05%-2.29%-19.91%-54.10% 203B
+0.55%-0.12%+30.04%+91.64% 181B
Average -0.70%-2.27%+24.80%+45.16% 370.33B
Weighted average by Cap. -0.87%-3.40%+36.11%+64.18%

Financials

2026 *2027 *
Net sales 11.39B 15.44B 13.29B 12.48B 21.4B 1,469B 21.55B 148B 57.53B 745B 57.96B 56.7B 2,466B 11.87B 16.09B 13.85B 13B 22.3B 1,531B 22.46B 154B 59.96B 776B 60.4B 59.09B 2,570B
Net income 1.7B 2.3B 1.98B 1.86B 3.19B 219B 3.21B 22.03B 8.57B 111B 8.63B 8.45B 367B 1.92B 2.6B 2.24B 2.1B 3.61B 248B 3.63B 24.93B 9.7B 126B 9.77B 9.56B 416B
Net Debt 6.87B 9.32B 8.02B 7.53B 12.91B 886B 13.01B 89.24B 34.72B 449B 34.98B 34.22B 1,488B 6.26B 8.49B 7.31B 6.86B 11.77B 808B 11.85B 81.31B 31.64B 410B 31.87B 31.18B 1,356B
Logo Haleon plc
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (31.4%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - pain relief medicines (23.2%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - respiratory medicines (17%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (15.3%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc.; - medicines for digestive health (8.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - other (4.2%). Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (41.6%), North America (35.1%), and Asia/Pacific (23.3%).
Employees
24,535
Date Price Change Volume
26-08-28 GBX 368.20 -0.35% 18,171,868
26-08-27 GBX 369.50 -1.02% 17,908,866
26-08-26 GBX 373.30 +1.00% 18,446,563
26-08-25 GBX 369.60 -0.05% 20,004,843
26-08-24 GBX 369.80 +1.85% 19,864,563
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
3.682GBP
Average target price
4.214GBP
Spread / Average Target
+14.45%

Quarterly revenue - Rate of surprise